The countdown is almost over! The 𝗘𝗦𝗖 𝗖𝗼𝗻𝗴𝗿𝗲𝘀𝘀 2024 kicks off in just a few days in London, and we're excited to connect with global experts in cardiovascular care. Our team of experts, including Diederick (Rick) E. Grobbee, MD, PhD, FESC, Ricard Quingles, Manuel Castro Cabezas, Marco Alings, and Elizabeth Liaño Callahan, will be there to discuss groundbreaking research and share insights. Make sure to visit us at booth #F520! Interested in setting up a meeting? Reach out to Elizabeth Liaño Callahan to secure a spot. See you in London! #ESC2024 #Cardiology
Julius Clinical
Geneesmiddelenproductie
Zeist, Utrecht 12.592 volgers
Julius Clinical manages global clinical drug trials that will have a major impact on medicine and make a real difference
Over ons
At Julius Clinical, science is the foundation. Combined with flexibility, creativity, and innovation, our scientific approach enables fast, efficient, and high quality execution of complex clinical development programs. Our skilled and loyal networks of investigators all around the world allow us to offer superior recruitment in therapeutic area’s such as cardiology, diabetes, CNS and infectious diseases. Our partners include leading pharmaceutical, biotech, medical device, and food companies, as well as academic investigators. We focus on clinical trials that are likely to have a major impact on medicine and on people’s lives. This type of demanding research requires more than a ‘one-size-fits-all’ approach, and our fusion of scientific and operational expertise enables to deliver results efficiently, on time and budget. Julius Clinical has on its staff internationally recognised academic leaders who are actively involved in the design, conduct, and interpretation of clinical trials. This scientific expertise and credibility, combined with personal links with peers around the world, means that the company has a truly global reach and reputation. Through our global networks we can quickly select the most appropriate and high-performing sites to take part in a trial, and ensure that investigators are inspired and motivated.
- Website
-
https://www.juliusclinical.com
Externe link voor Julius Clinical
- Branche
- Geneesmiddelenproductie
- Bedrijfsgrootte
- 51 - 200 medewerkers
- Hoofdkantoor
- Zeist, Utrecht
- Type
- Particuliere onderneming
- Opgericht
- 2008
- Specialismen
- clinical trials, academic & operational excellence, research, CNS diseases, infectious diseases, cardiovascular diseases, metabolic diseases, science en clinical research
Locaties
-
Primair
Routebeschrijving
Broederplein 41-43
Zeist, Utrecht 3703CD, NL
Medewerkers van Julius Clinical
-
Merel Schoonmade
Chief People Officer @ Julius Clinical
-
Stefan Timmerman MSc RC
-
Jan Hille Noordhof
+31 6 52 52 7 456 Owner People Plus; Organisation Development; Moderator VPRO Tegenlicht; Author; Speaker & Listener; Coach
-
Jon Bouwman
Associate Director Site Management Organisation at Julius Clinical
Updates
-
Next month ReSViNET | Respiratory Syncytial Virus (RSV) Foundation will organize the webinar '𝐑𝐞𝐜𝐨𝐧𝐜𝐞𝐩𝐭𝐮𝐚𝐥𝐢𝐬𝐢𝐧𝐠 𝐑𝐒𝐕 𝐢𝐧 𝐚𝐝𝐮𝐥𝐭𝐬: 𝐆𝐞𝐭𝐭𝐢𝐧𝐠 𝐫𝐞𝐚𝐝𝐲 𝐭𝐨 𝐞𝐯𝐚𝐥𝐮𝐚𝐭𝐞 𝐧𝐞𝐰 𝐭𝐫𝐞𝐚𝐭𝐦𝐞𝐧𝐭 𝐨𝐩𝐭𝐢𝐨𝐧𝐬'. This webinar will be presented by guest speaker Dr. Christopher Butler and hosted by Prof. Louis Bont. For more info and to register, visit: https://lnkd.in/eZ7CbJ3J
𝐑𝐄𝐆𝐈𝐒𝐓𝐄𝐑 𝐍𝐎𝐖! We are very excited to share that our next webinar is coming soon! The topic is 𝐑𝐞𝐜𝐨𝐧𝐜𝐞𝐩𝐭𝐮𝐚𝐥𝐢𝐬𝐢𝐧𝐠 𝐑𝐒𝐕 𝐢𝐧 𝐚𝐝𝐮𝐥𝐭𝐬: 𝐆𝐞𝐭𝐭𝐢𝐧𝐠 𝐫𝐞𝐚𝐝𝐲 𝐭𝐨 𝐞𝐯𝐚𝐥𝐮𝐚𝐭𝐞 𝐧𝐞𝐰 𝐭𝐫𝐞𝐚𝐭𝐦𝐞𝐧𝐭 𝐨𝐩𝐭𝐢𝐨𝐧𝐬. This webinar will be presented by our guest speaker Dr. Christopher Butler and hosted by Prof. Louis Bont. ✍REGISTER: 𝐅𝐨𝐫 𝐟𝐫𝐞𝐞 𝐨𝐧 𝐭𝐡𝐞 𝐑𝐞𝐒𝐕𝐢𝐍𝐄𝐓 𝐰𝐞𝐛𝐬𝐢𝐭𝐞 💡TOPIC: 𝐑𝐞𝐜𝐨𝐧𝐜𝐞𝐩𝐭𝐮𝐚𝐥𝐢𝐬𝐢𝐧𝐠 𝐑𝐒𝐕 𝐢𝐧 𝐚𝐝𝐮𝐥𝐭𝐬: 𝐆𝐞𝐭𝐭𝐢𝐧𝐠 𝐫𝐞𝐚𝐝𝐲 𝐭𝐨 𝐞𝐯𝐚𝐥𝐮𝐚𝐭𝐞 𝐧𝐞𝐰 𝐭𝐫𝐞𝐚𝐭𝐦𝐞𝐧𝐭 𝐨𝐩𝐭𝐢𝐨𝐧𝐬 📅DATE: 𝐓𝐮𝐞𝐬𝐝𝐚𝐲, 𝐒𝐞𝐩𝐭𝐞𝐦𝐛𝐞𝐫 𝟏𝟕𝐭𝐡, 𝟐𝟎𝟐𝟒 ⌛TIME: 𝟏𝟔:𝟎𝟎-𝟏𝟕:𝟎𝟎 𝐂𝐄𝐒𝐓 (Central European Summer Time) #RSV #Webinar #ReSViNET
-
-
Our colleagues Diederick (Rick) E. Grobbee, MD, PhD, FESC, Ricard Quingles, Manuel Castro Cabezas, Marco Alings and Elizabeth Liaño Callahan will be attending the 𝗘𝗦𝗖 𝗖𝗼𝗻𝗴𝗿𝗲𝘀𝘀 2024 in London from August 30 to September 2! This year’s theme, "Personalising Cardiovascular Care," will explore tailored treatments to enhance patient outcomes and set new standards in cardiovascular medicine. 𝗪𝗲’𝗿𝗲 𝗲𝘅𝗰𝗶𝘁𝗲𝗱 𝘁𝗼 𝗯𝗲 𝗽𝗮𝗿𝘁 𝗼𝗳 𝘁𝗵𝗶𝘀 𝗴𝗹𝗼𝗯𝗮𝗹 𝗰𝗮𝗿𝗱𝗶𝗼𝗹𝗼𝗴𝘆 𝗲𝘃𝗲𝗻𝘁 𝗮𝗻𝗱 𝗶𝗻𝘃𝗶𝘁𝗲 𝘆𝗼𝘂 𝘁𝗼 𝘃𝗶𝘀𝗶𝘁 𝘂𝘀 𝗮𝘁 𝗯𝗼𝗼𝘁𝗵 #F520. Interested in scheduling a meeting in advance? Feel free to contact Elizabeth Liaño Callahan directly.
-
-
Next week Helen Blackshaw will be attending the 4th Inner Ear Disorders Therapeutics Summit in Boston from August 20-22. If you're attending, make sure to connect with her, she's looking forward to meeting you!
Excited to announce that our colleague, Helen Blackshaw, will be attending the 4𝐭𝐡 𝐈𝐧𝐧𝐞𝐫 𝐄𝐚𝐫 𝐃𝐢𝐬𝐨𝐫𝐝𝐞𝐫𝐬 𝐓𝐡𝐞𝐫𝐚𝐩𝐞𝐮𝐭𝐢𝐜𝐬 𝐒𝐮𝐦𝐦𝐢𝐭 in Boston from August 20-22, 2024. With groundbreaking advances in gene therapies, small molecules, and cell therapies for hearing disorders, this summit is set to be a pivotal event in the field. Helen is eager to connect with industry experts and discuss the latest innovations and challenges in inner ear therapeutics. If you're attending, make sure to connect with her.
-
-
Over the past few days, our colleagues Lieza G. Exalto and Maria Papakrasa have been at #AAIC2024. It has been an amazing congress filled with inspiring talks and the opportunity to meet wonderful people. If you didn't get the chance to meet our colleagues, please feel free to reach out. We're already excited for next year's #AAIC in Toronto! https://lnkd.in/eQsnh3iE
#AAIC24 what a wonderful conference, great talks and people. Unfortunately, already on my way home. If I have missed you, feel free to reach out! Already looking forward to AAIC in Toronto!
-
-
Join our team as a Project Compliance Manager! Are you an experienced CRA or Clinical Team Lead passionate about process alignment and knowledge sharing in international clinical trials? Julius Clinical wants you! As a Project Compliance Manager, you'll develop procedures, conduct compliance checks, and train teams, ensuring operational excellence across international trials. For more information, read the full vacancy or contact Ellen Hunink, HR Business Partner.
-
The countdown has begun! Just 10 days until the #AAIC kicks off, where our colleagues Lieza G. Exalto and Maria Papakrasa will be representing Julius Clinical. We invite you to connect with our team and schedule a meeting during the conference to discuss the latest advancements in Alzheimer's research.
-
-
𝗪𝗲'𝗿𝗲 𝗹𝗼𝗼𝗸𝗶𝗻𝗴 𝗳𝗼𝗿 𝗮 𝗵𝗶𝗴𝗵𝗹𝘆 𝗺𝗼𝘁𝗶𝘃𝗮𝘁𝗲𝗱 𝗔𝗰𝗰𝗼𝘂𝗻𝘁𝗶𝗻𝗴 𝗔𝗱𝗺𝗶𝗻𝗶𝘀𝘁𝗿𝗮𝘁𝗼𝗿 𝘁𝗼 𝗷𝗼𝗶𝗻 𝗼𝘂𝗿 𝘁𝗲𝗮𝗺. Under the direction of the CFO, you will be responsible for setting up and executing all financial administrative processes and reporting. Your role will ensure a correct, complete, and timely financial administrative process, continuously supporting the Finance Team and other departments. Interested? Learn more and apply here: https://lnkd.in/eg258ywj or contact Ellen Hunink
-
Our colleague Lotte Smets, will be speaking at 𝗥𝗕𝗤𝗠𝗟𝗶𝘃𝗲 𝟮𝟬𝟮𝟰 this September! She will present on “𝗥𝗕𝗤𝗠 𝗜𝗻𝗱𝘂𝘀𝘁𝗿𝘆 𝗚𝘂𝗶𝗱𝗮𝗻𝗰𝗲 𝗘𝘃𝗼𝗹𝘂𝘁𝗶𝗼𝗻 – 𝗔𝗱𝗮𝗽𝘁𝗶𝗻𝗴 𝘁𝗼 𝗠𝗼𝗱𝗲𝗿𝗻𝗶𝘇𝗮𝘁𝗶𝗼𝗻,” sharing valuable insights that could transform your next clinical trial. Learn more about RBQMLive here: https://lnkd.in/epWdkwAU Can't wait until September 2024 to discover how we can transform your clinical trial? Contact Lotte Smets directly for more information. https://lnkd.in/e3Pj6wJz
Big news! Lotte Smets will be taking the virtual stage at RBQMLive 2024 in September to present “RBQM Industry Guidance Evolution – Adapting to Modernization.” These are insights that can make a real difference in your next clinical trial. Registration is OPEN! 👉 https://hubs.ly/Q02Gf68L0 #RBQMLive2024 #RBQM #ClinicalTrials #ClinicalResearch
-
-
Missed our recent MASH webinar '𝗖𝗹𝗶𝗻𝗶𝗰𝗮𝗹 𝗰𝗼𝗻𝘀𝗲𝗾𝘂𝗲𝗻𝗰𝗲𝘀 𝗼𝗳 𝘁𝗵𝗲 𝗻𝗲𝘄 𝗠𝗔𝗦𝗟𝗗 𝗻𝗼𝗺𝗲𝗻𝗰𝗹𝗮𝘁𝘂𝗿𝗲' ? Replay available now: https://lnkd.in/dBK7ZQha During this webinar, Prof. Maja Thiele delved into crucial topics such as the prognostic relevance of MASLD classifications and the necessity of re-validating Non-Invasive Liver Tests (NILTs) under the new guidelines. https://lnkd.in/eK95nsjy
In our recent MASH webinar, we were honored to have Prof. Maja Thiele present on '𝗖𝗹𝗶𝗻𝗶𝗰𝗮𝗹 𝗰𝗼𝗻𝘀𝗲𝗾𝘂𝗲𝗻𝗰𝗲𝘀 𝗼𝗳 𝘁𝗵𝗲 𝗻𝗲𝘄 𝗠𝗔𝗦𝗟𝗗 𝗻𝗼𝗺𝗲𝗻𝗰𝗹𝗮𝘁𝘂𝗿𝗲'. Hosted by Prof. Manuel Castro Cabezas and Prof. Christophe Moreno, this session offered profound insights into the impact of disease prevalence on non-invasive diagnostic methods, the role of lifestyle changes in patient care, and the enhancement of MASH management through clinical pathways. 𝗧𝗵𝗲 𝗿𝗲𝗽𝗹𝗮𝘆 𝗶𝘀 𝗻𝗼𝘄 𝗮𝘃𝗮𝗶𝗹𝗮𝗯𝗹𝗲. 𝗪𝗮𝘁𝗰𝗵 𝗵𝗲𝗿𝗲: https://lnkd.in/dBK7ZQha
Webinar: Clinical consequences of the new MASLD nomenclature
https://vimeo.com/